搜索结果：medRxiv

Neuroinflammation is a key component of the response to injury after concussion, but direct links between diffusion MRI metrics and specific plasma inflammatory pathways in human concussion have not been established. To examine associations between diffusion MRI metrics and pathway-level inflammatory proteomic signatures in adolescents during the subacute period after concussion. Cross-sectional analysis of data from the CARE4Kids Consortium, a six-site prospective study. Participants were English-speaking adolescents ages 11-17.99 with concussion and symptoms at 7-35 days post-injury. Data were collected between 2022-2024. Of 370 enrolled participants, 122 had both diffusion MRI and plasma proteomics available for analysis. Advanced diffusion MRI metrics were converted to z-scores and participants were grouped by the spatial extent of outlier values (potholes and peaks) across 15 white matter regions of interest. Nine non-redundant groupings were selected for primary analysis. Pathway-level inflammatory profiles derived from gene set enrichment analysis (GSEA) of ∼5,400 plasma proteins measured by Olink proximity extension assay, targeting nine hallmark inflammatory pathways spanning initiation through resolution. Persistent symptoms were assessed 64-115 days post-injury. Diffusion metrics reflecting tissue disorganization were associated with upregulation of the coagulation pathway, consistent with hemostatic-inflammatory signaling. Metrics reflecting reduced tissue complexity and neurite density were associated with upregulation of interferon-α and interferon-γ response pathways, consistent with microstructural remodeling driven by cellular immune activation. Elevated free water content was associated with downregulation of most inflammatory pathways and trend-level transforming growth factor - β upregulation, reflecting inflammatory resolution. Time since injury did not differ between groups based on free water (Kolmogorov-Smirnov p = 0.97), suggesting these differences reflect individual variability in recovery pace. Exploratory analyses showed a trend toward lower odds of persistent symptoms in the group with elevated free water content (odds ratio = 0.51, p = 0.18). Multiple diffusion MRI metrics are differentially sensitive to distinct neuroinflammatory states in the subacute period after adolescent concussion. These findings suggest that diffusion imaging could serve as a non-invasive tool for inflammatory phenotyping, with potential implications for identifying patients who may benefit from targeted immunomodulatory intervention. Question: Are specific diffusion MRI metrics sensitive to distinct inflammatory pathway signatures in adolescents during the subacute period after concussion?Findings: In this cross-sectional study of 122 adolescents with concussion, multimodal diffusion MRI metrics were associated with mechanistically distinct proteomic signatures rather than a uniform inflammatory response. Metrics reflecting tissue disorganization were associated with hemostatic-inflammatory pathway upregulation, metrics reflecting reduced tissue complexity and neurite density were associated with interferon signaling and coagulation suppression, and elevated free water content was associated with inflammatory pathway downregulation and trend-level resolution-phase signaling.Meaning: Different diffusion MRI metrics are sensitive to qualitatively different neuroinflammatory processes, suggesting that multimodal diffusion imaging may enable non-invasive profiling of the post-injury inflammatory state and inform targeted therapeutic strategies.

Polygenic risk scores (PRS) for posttraumatic stress disorder (PTSD) often account for a low amount of variance. Ancestry-related differences in PRS scale and variance limit cross-group comparisons. This methodological challenge further complicates gene-by-environment (GxE) analyses, given that socioenvironmental exposures are inequitably distributed across ethnoracial groups. We constructed an ancestry-calibrated polygenic risk score (AC-PRS) for PTSD in the largest longitudinal study of trauma survivors to date and investigated GxE interactions. Recent trauma survivors (N=1,801) provided a blood specimen for genotyping. Six PTSD trajectories were previously identified from PTSD Checklist for DSM-5 (PCL-5) scores at 2-weeks, 8-weeks, 3-months, and 6-months post-trauma. Greenspace (normalized difference vegetation index [NDVI) and socioeconomic disadvantage (area deprivation index [ADI]) were derived from residential addresses. Logistic regressions examined interactions between newly developed AC-PRS and neighborhood factors on trajectories after adjusting for sociodemographic and trauma-related covariates. Secondary linear models considered GxE interactions on 6-month PCL-5 scores. AC-PRS performed well across ethnoracial groups, explaining significant variability in PTSD trajectories (R 2 =.053). ADI moderated the association between AC-PRS and the likelihood of assignment in a high nonremitting trajectory of PTSD symptoms and severity of symptoms at 6-months ( ps < .05). There were no NDVI x AC-PRS interactions in any models. AC-PRS captures genetic risk for PTSD in admixed trauma survivors, demonstrating good discrimination between nonremitting and resilient courses of PTSD. However, neighborhood disadvantage may modify utility of PRS for PTSD, warranting careful consideration when applying these scores across contexts.

Youth with HIV experience persistent disparities across the HIV care continuum, including low rates of engagement in care and viral suppression. In a recent national survey, youth and young adults, defined by the CDC as ages 13-34, accounted for approximately 20- 40% of new HIV diagnoses in the United States. We describe the Intervention for Virological Suppression in Youth with HIV (iVY), a youth-friendly, tailored approach that integrates mental health and substance use support with HIV treatment engagement. This paper describes the development of the intervention used in iVY, which is currently being evaluated in a randomized clinical trial (RCT) using an adaptive treatment strategy. HIV virological suppression is measured via dried blood spot at 16 weeks. The intervention is delivered fully remotely across California and Florida. YWH aged 18-29 who are not durably virally suppressed are enrolled and randomized to the intervention or usual care. The RCT will enroll and randomize 200 participants to the intervention ( n = 100) versus usual care ( n = 100). iVY includes: (1) tailored brief, weekly video-counseling sessions focused on HIV treatment adherence and engagement, mental health, substance use, and related barriers; and (2) a mobile health application designed to support adherence, resource access, and peer connection. Participants who are not virally suppressed receive an additional 16 weeks of intensified intervention, while responders continue with app-based support. N/A. This paper provides a detailed description of a telehealth-based behavioral intervention tailored to the needs of youth with HIV. The intervention offers a scalable model for integrating behavioral health and HIV care to address barriers to treatment engagement in this priority population.

We previously reported inherited ROR&#x3b3;T deficiency in seven patients from three ancestries (Chilean, Palestinian, Saudi Arabian) with mycobacterial disease and chronic mucocutaneous candidiasis (CMC). We report here five additional patients from different ancestries (Afghan, Indian, Iranian, Japanese, Sri Lankan), each homozygous for a new loss-of-function RORC variant. All but one patient - the exception receiving early prophylaxis - developed mycobacterial disease due to a near-complete depletion of innate-like adaptive T cells, including MAIT and iNKT cells, low counts of adaptive T H 1* and CD8 + T cells, and impaired Mycobacterium -induced IFN-&#x3b3; production by the remaining cells of these subsets, NK cells, conventional CD4 + T, V&#x3b4;1, and V&#x3b4;2 &#x3b3;&#x3b4;T cells. Most patients also displayed CMC due to their low counts of T H 17 and T H 1* cells. One patient died from disseminated Bacille Calmette-Gu&#xe9;rin (BCG) vaccine infection, but, unexpectedly, all the other patients are still alive and clinically stable. ROR&#x3b3;T is essential for protective immunity against mycobacteria and Candida in humans.

Traumatic brain injury (TBI) is a leading cause of death and long-term disability in children, with many experiencing persistent symptoms even after mild TBIs. Exposure to adverse childhood experiences (ACEs) can have physiological effects that may alter how the brain responds to injury, yet the effects of ACEs on white matter injury and recovery processes remain unclear. This study examined whether a history of ACEs is associated with patterns of longitudinal change in white matter microstructure in children with mTBI. Ninety-six concussed adolescents (mean age=14.9 years, range =11.4-17.9, 51% female) from the CARE4Kids consortium completed the Pediatric ACEs and Related Life-Events Screener and underwent diffusion-weighted MRI at baseline (7-35 days after injury) and follow-up (2 months later). Fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), radial diffusivity (RD), orientation dispersion index (ODI), and intracellular volume fraction (ICVF) were estimated using tract-based spatial statistics and harmonized across sites. Differences in the magnitude and direction of change in diffusion metrics over time were examined in 15 tracts of interest. Higher ACE exposure was associated with smaller absolute change in AD, MD, ODI, and ICVF across several white matter tracts, including the corpus callosum, internal and external capsules, corona radiata, and posterior thalamic radiation. Groups did not differ in the direction of white matter change for any tract-metric combination. These findings suggest that ACE exposure may blunt white matter reactivity to injury and/or reorganization during recovery processes.

Validated measures of pain catastrophizing primarily assess catastrophizing as a stable trait. However, emerging evidence suggests catastrophizing fluctuates with context, highlighting a need for ecologically valid methods to capture it. This study evaluated large language models (LLMs) as implicit markers of catastrophizing from free-text responses from ninety-one adults with chronic pain receiving long-term opioid therapy (57.3% Female; mean age = 60.5 years). Patients completed baseline measures, including the trait pain catastrophizing scale (PCS), followed by a 10-minute writing task after random assignment to a negative, positive, or neutral pain-coping condition. State affect and pain were assessed before and after writing tasks and again after a cold pressor task (4&#xba;C; &#x2264; 2 minutes). A state PCS followed the cold pressor task. Free-text responses were analyzed using four LLMs (Claude Opus 4; GPT Mini 4o; Llama 4 Maverick; and Gemini 2.5 Pro). ANOVA-based results supported discriminant validity, as all four LLM-derived pain catastrophizing scores differentiated negative from positive and neutral pain-coping conditions. Convergent validity was model-dependent; only Gemini-derived scores correlated with state catastrophizing (r = .22) and pain unpleasantness (r = .23). Divergent validity was mixed. LLM-derived scores were unrelated to pain intensity, but Gemini and Claude-derived scores showed small correlations with trait PCS (r's = .21; 28, respectively). All LLM-derived scores also correlated with negative affect (r's = .29-.41), comparable in magnitude to state PCS, suggesting limited specificity. These findings provide preliminary evidence that certain LLMs may serve as implicit markers of state pain catastrophizing, but further study is needed. Leading Large Language Models (LLMs) demonstrate discriminant validity but mixed convergent and divergent validity scoring pain catastrophizing from persons living with chronic pain free-text responses.

The Diabetes Prevention Program (DPP) was a randomized clinical trial designed to prevent type 2 diabetes (T2D) in adults with prediabetes. The DPP Outcomes Study (DPPOS) is the 30-year follow-up of this cohort, focusing on T2D, prediabetes, and related complications. Cognitive assessments began in 2009 and expanded in 2022 to examine cognitive impairment, including Alzheimer's disease (AD) and AD related dementias (ADRD), in the surviving cohort. To support these aims, the National Alzheimer's Coordinating Center Uniform Data Set version 3 (NACC-UDSv3), the standardized framework used by Alzheimer's Disease Research Centers, was implemented in DPPOS in 2022 to enable data sharing with NACC. These forms were complemented by cognitive tests administered in DPPOS. We aimed to integrate the NACC-UDSv3 into the existing longitudinal DPPOS framework while maintaining fidelity to its structure and developing automated reports to streamline cognitive outcomes adjudication. Items from the 16 NACC-UDSv3 data forms were compared with those already collected within DPPOS to integrate overlapping similar items, add missing NACC-UDSv3 items, and create a dataset harmonized with NACC-UDSv3. Forms were adapted for electronic data capture (EDC) using the MIDAS (Multimodal Integrated Data Acquisition System, George Washington University). Automated reports integrated current and prior neuropsychological scores to support adjudications. In the first wave of the DPPOS-AD/ADRD study, 1561 cognitive adjudications were successfully completed using the harmonized DPPOS and NACC-UDSv3 data implemented into MIDAS. The DPPOS-AD/ADRD project demonstrated that NACC-UDSv3 can be successfully integrated into a long-standing longitudinal cohort not originally designed for AD/ADRD research. The harmonization, electronic capture, and automated adjudication processes may provide a practical framework for other cohorts seeking to incorporate NACC-UDSv3 to align with national AD/ADRD research standards.

Nonresponse to routinely collected patient-reported outcome measures (PROMs) threatens the representativeness of aggregated data. We characterized patient-, provider-, and clinic-level factors associated with PROMIS Global-10 nonresponse in routine radiation oncology care. In this retrospective cohort study, all adults seen at five Mass General Brigham radiation oncology clinics over one year were included. The primary outcome was patient-level nonresponse, defined as never completing the portal-administered Global-10 versus completing it at least once. Using iterative mixed-effects logistic regression, we modeled patient-, provider-, and clinic-level factors. Among 12,214 patients, 71 providers, and five clinics, patient- and appointment-level response rates were 35.4% and 10.9%, with patient-level response ranging nearly fivefold across clinics (12.8% to 66.2%). In Model 1, male sex, lower education, not working, and recent surgery had higher odds of nonresponse, and longer time since diagnosis lower odds. After provider- and clinic-level factors were added, patient sex, education, and employment became nonsignificant, whereas recent surgery (adjusted odds ratio [aOR] 1.97) and longer time since diagnosis (aOR 0.46 for >12 months) persisted. A provider's historical collection rate was protective but attenuated at the clinic level. There, a later program launch (aOR 0.29) and higher historical collection rate (aOR 0.79) correlated with lower nonresponse, whereas academic versus community setting did not. Nonresponse to routinely collected PROMs is a multilevel phenomenon driven substantially by clinic-level implementation factors, not patient characteristics alone. Because response rate is only a proxy for representativeness, PROMs programs and PRO-based performance measures should prioritize representative collection over volume.

Efficiently summarizing dietary records at scale remains a persistent bottleneck in nutritional epidemiology. We present FoodScribe, which translates free-text meal descriptions into quantitative nutrient profiles by combining ingredient parsing with nutrient retrieval by querying the USDA FoodData Central (FDC) database. Benchmarked using three LLM providers using Nutribench dataset, FoodScribe completed annotation of 3,807 meal descriptions in 2.5 hours, a task otherwise requiring substantial manual effort from trained nutritionists. FoodScribe achieved accuracy across macronutrient estimation (F1=0.79-0.89), with models performing better for protein than fat estimation. Application to a Mediterranean diet intervention cohort indicated dietary shifts consistent with the intervention pattern based on model-derived estimates. Integration with metabolomics data suggested that fiber and vegetable intake were positively associated with a fecal metabolite cluster.

Palliative care is recommended by clinical practice guidelines for patients with advanced heart failure (aHF), yet specialty palliative care (SPC) remains substantially underutilized in this population. We sought to quantify between-facility variation in SPC receipt among people with aHF and determine how much variation is explained by patient case mix and facility structural characteristics versus residual unmeasured factors. This retrospective cohort study included 23,991 Veterans with prevalent aHF identified through administrative data across 133 VA Medical Centers (VAMCs) with &#x2265;20 aHF cases, from January 2022 to December 2023. Variation was assessed using multilevel logistic regression with facility random intercepts, the intraclass correlation coefficient (ICC), and the adjusted median odds ratio (aMOR). Facility-specific risk-standardized SPC rates were used to estimate SPC encounters attributable to facility performance better or worse than the national rate. Of the sample, the mean patient age was 72.3 years (SD = 10.0), and 97.6% were male. The national observed rate of SPC was 17.5%, with risk-adjusted rates varying approximately 14-fold across facilities (3.3% to 45.6%). The adjusted ICC was 11.5%, and aMOR was 1.87 (95% Confidence Intervals 1.70-2.06). Measured patient case-mix and facility structural characteristics explained only 18.9% of between-facility variation (proportional reduction in the ICC, fully adjusted vs. null model). Facilities performing better than the national rate delivered 791 more SPC encounters than expected (17.8%), while those performing worse than the national rate delivered 480 fewer encounters than expected (10.8%). In the context of a national mean rate of SPC that reflects substantial underuse, delivery varied 14-fold across VAMCs, with most variation unexplained by patient complexity or measured facility resources. These findings suggest that potentially modifiable organizational factors, beyond patient preferences or facility structures alone, may contribute to current utilization gaps and represent actionable targets for quality improvement. What is new?: In this national cohort of 23,991 people with advanced heart failure cared for at 133 VA Medical Centers, risk-adjusted rates of specialist palliative care delivery varied 14-fold across facilities (median odds ratio 1.87). Measured patient case-mix and facility structural characteristics explained only 18.9% of the between-facility variation.Clinical implications?: Substantial variation in palliative care delivery across VAMCs is not accounted for by differences in patient complexity or facility resources, suggesting that institutional processes and referral practices are key drivers and represent actionable targets for quality improvement.

Traumatic brain injury (TBI) severity is typically classified using clinical indices that may have limited prognostic value. Objective measures of olfactory function depend on sensory, limbic, and memory networks and may provide a more specific marker of injury-related neural dysfunction. Seventy-nine individuals with TBI (48 mild, 31 moderate-to-severe) and 59 healthy controls completed an olfactory battery, including tests of odor percept identification (OPID9, OPID18), odor discrimination (OD10), and odor memory (POEM) &#x223c;4.04 (4.45) years after their most recent TBI. General linear models examined associations between olfactory outcomes and TBI severity, adjusting for age, age&#xb2;, sex, and education. Additional models examined the relationship between loss of consciousness (LOC) and olfactory functioning. The severity of the most recent TBI was significantly associated with all olfactory outcomes, after adjusting for age, sex, and education. Compared with controls, participants with moderate- to-severe TBI showed lower OPID9, OPID18, POEM, and OD10 performance, while participants with mild TBI showed lower OPID18 and POEM performance. LOC was associated specifically with odor memory in these models, as participants with prolonged (> 30min) LOC or LOC of unknown duration had lower POEM scores than those with no LOC. In TBI-only models, LOC remained associated with POEM after adjustment for TBI severity, whereas TBI severity was not associated with POEM after LOC was included. Long term olfactory functioning is sensitive to TBI severity, with generalized impairments across odor identification, discrimination, and odor memory. LOC characteristics appear especially relevant to odor memory, suggesting that olfactory memory may capture injury-related features beyond TBI severity classification alone.

Metformin remains the primary treatment for type 2 diabetes, yet over 40% of patients fail to maintain glycaemic control. We aimed to identify patients unlikely to respond to metformin prior to treatment initiation and to evaluate whether on-treatment management can improve glycaemic outcomes in suboptimal responders, informing early treatment decisions. We analyzed 59,881 longitudinal HbA1c measurements from 7,105 patients with type 2 diabetes receiving metformin monotherapy using real-world electronic health records from Kaiser Permanente Northern California with up to six years of follow-up. We integrated demographic, clinical, genetic, and pharmacological factors to characterize metformin responder phenotypes and quantify the impact of adherence and weight control on time to glycaemic failure. Three distinct trajectory-based phenotypes were identified: good (63.6%), poor (8.9%), and non-responders (27.5%). Poor responders initially achieved glycaemic targets but lost control within 2.5 years, while non-responders showed minimal HbA1c reduction and failed within 1 year. Five baseline factors-HbA1c, age at diagnosis, body mass index, sex, and estimated glomerular filtration rate-classified phenotypes with good discrimination (area under the receiver operating characteristic curve = 0.84). Incorporating on-treatment HbA1c further enhanced identification of non-responders. Among suboptimal responders, weight control and improved adherence delayed glycaemic failure by approximately 7 months; however, eventual glycaemic failure remained likely. We characterized three clinically relevant metformin responder phenotypes and showed that suboptimal responders can be identified early using baseline features. Poor and non-responders are unlikely to achieve durable glycaemic control with metformin alone and may require alternative treatment strategies.

Airway remodeling is a convergent feature across respiratory diseases, yet current CT tools provide limited characterization of the airway tree. We present Radiomics of the Airway (RadAr), an automated framework for multi-scale airway phenotyping from routine chest CT. RadAr extracts multi-scale, interpretable airway measurements capturing luminal dimensions, tapering, architectural distortion, and global morphology and provides an interactive web portal for analysis and visualization. It was evaluated across four settings: 63-week mortality prediction in fibrotic interstitial lung disease (fILD; N=147), COVID-19 severity prediction (N=1164), structure-function association in progressive pulmonary fibrosis (PPF; N=9) and structure-inflammation markers in pediatric cystic fibrosis (CF; N=11). Unsupervised clustering identified airway phenotypes across the fILD and COVID-19 cohorts. In fILD, lower-lobe architectural distortion was associated with mortality (balanced accuracy 0.654). In COVID-19, severe disease was independently associated with luminal dilation (AUC 0.719, odds ratio 2.32, p=0.017). In PPF, airway phenotypes correlated with forced vital capacity (&#x3c1;=0.83), mid-expiratory flow (&#x3c1;=0.87), and &#xb9;&#xb2;&#x2079;Xe MRI alveolar gas exchange impairment (&#x3c1;=0.70). In pediatric CF, reduced tapering and increased cylindricity were associated with prior exacerbations and bronchoalveolar lavage neutrophilia (&#x3c1;=-0.64 to -0.78). Five phenotypes were identified from extensive, tapered airway trees to sparse, dilated, thick-walled, tortuous trees, with increasing COVID-19 severity and fILD mortality across this spectrum. RadAr identified interpretable, disease-specific airway signatures associated with function and outcomes across restrictive, obstructive, and mixed lung diseases in adult and pediatric settings. It provides a scalable framework that may support diagnosis, risk stratification, and longitudinal monitoring across pulmonary diseases.

People with Down syndrome have higher age-specific mortality rates compared to the general population as well as peers with other intellectual and developmental disabilities. While a large proportion of mortality is attributable to Alzheimer's disease, many die prior to Alzheimer's diagnosis and some live to old ages, dying without Alzheimer's. Our objectives were to use 11 years of Medicaid and Medicare data to describe characteristics and factors related to death in adults with Down syndrome and use machine learning to identify which conditions most strongly predict death in the full population and stratified by age. We identified death using Center for Medicare and Medicaid Systems reported date of death health conditions using ICD 9 and 10 codes. We used a case-control design with risk set sampling to have that controls to mimic the distribution of times of incident Alzheimer's disease. We trained gradient boosted trees to identify strongest predictors. Our cohort included 137,293 adults with Down syndrome. Among those, 30,894 (22.5%) died during the study period. Mean age at death among those who died was 55 years (SD=10). Mean age of death in those with Alzheimer's disease was 59 (SD=7) and those without was 52 (SD=12). The most influential predictors of mortality were any claim for dementia, any claim for pneumonia, re-occurring claim for cardiovascular disease three years before index death, and any claim for heart failure and epilepsy. Our results align with previous clinical work and highlight intervenable areas to reduce mortality in the Down syndrome population.

Clostridioides difficile is the leading cause of healthcare acquired infections (HAIs). Healthcare systems lack scalable strategies to identify patients colonized with toxigenic strains to inform prevention programs. We developed a scalable program using rectal swabs, collected for vancomycin resistance Enterococci surveillance, with ex vivo amplification of C. difficile in Cdiff Banana Broth (BB). Optimized confirmatory testing of BB-positive tubes used the rapid C. difficile QuickCheck assay with Cepheid's Xpert&#xae; C. difficile/Epi (Xpert) to confirm toxin gene carriage for QuickCheck results of C. difficile glutamate dehydrogenase-positive (GDH) and antigenic toxin-negative. BB with confirmation demonstrated 92% specificity and 100% sensitivity, to a limit of <5 colony forming units (CFU)/swab, versus published values of 100/swab by ChromID&#xae; C. difficile agar and 460/swab by direct Xpert swab testing. The two-step confirmation detected toxigenic C. difficile in cases missed by other methods. Prospective testing of 797 VRE swabs from 538 ICU and inpatient oncology patients seen at an academic medical center and two community hospitals demonstrated 11% positivity for toxigenic and 4% for non-toxigenic C. difficile. Among swabs, 32% of toxigenic C. difficile were resulted at 24 hours and 68% at 48 hours. Addition of 17% glycerol to BB-positive aliquots, for -80&#xb0;C storage, supported 100% retrieval of C. difficile 7 months later. BB with confirmation provides a more sensitive method to detect patient colonization with toxigenic C. difficile and, by using VRE surveillance swabs, does not require additional patient samples. The simplified approach can be deployed across healthcare settings to support C. difficile -prevention programs. C. difficile infections are the most prevalent HAIs, causing substantive mortality, morbidity, and economic burden. Among HAIs, C. difficile remains the one pathogen lacking scalable surveillance strategies for clinical microbiology labs. We present an optimized strategy to enable C . difficile surveillance testing across broad clinical settings to enable prevention programs for this pathogen.

Real-time forecasts of seasonal respiratory outbreaks are critical for public health preparedness and healthcare planning. Multi-model ensembles, which combine predictions from individual models, have become a leading approach for operational outbreak forecasting. Their success, however, depends in part on the assumption that component models make sufficiently independent errors. Here, we examined this assumption using archived real-time forecasts for influenza hospitalizations and influenza-like illness (ILI) in the United States. We found that component models with diverse structures and calibration methods shared systematic forecast errors during epidemic growth and around epidemic peaks, reflecting the common challenge of tracking rapid changes in epidemic dynamics from real-time surveillance data. Because such shared errors cannot be fully corrected by ensembling alone, we developed a deep learning framework that learns structured residual errors from historical forecasts and uses them to correct ensemble predictions. This framework improved influenza hospitalization forecasts across horizons and geographic scales, reducing the Weighted Interval Score by up to 20% at the national level and 12% across states relative to official ensemble forecasts, with the largest improvements at the near-term horizon and during epidemic growth and peak periods. We further showed that learned residual structures transferred across ensembles formed from different component models, making the approach robust to changes in model participation across seasons. The framework also improved ensemble forecasts for ILI, although gains were more modest. These findings reveal a fundamental challenge in ensemble forecasting and provide a generalizable approach for improving real-time epidemic forecasts.

Until 2020, two lineages of the influenza B virus had co-circulated globally. Measures to control the COVID-19 pandemic led to a near-absence of influenza infections. While B/Victoria reemerged in late 2021, there have been no reports of B/Yamagata since the pandemic. To investigate which epidemiological and immunological factors were primarily responsible for the extinction of B/Yamagata, we developed a global model for the two influenza B lineages. To mimic the transmission impacts of the pandemic, we implemented a transient reduction in contacts and identified parameter values that recapitulated viral coexistence dynamic before the pandemic and the qualitative post-pandemic outcomes of B/Victoria (reemergence in late 2021) and B/Yamagata (extinction). Our results suggest that, rather than immunological or evolutionary mechanisms, the extinction of B/Yamagata was mainly driven by its lower basic reproduction number making the virus particularly vulnerable during the early phase of the pandemic. Stochastic simulations of our best-fitting model suggest that B/Victoria was also close to extinction during this period. We investigate the model to assess the feasibility of B/Victoria eradication through vaccination and the potential for a sustained re-emergence of B/Yamagata in the 2026-27 flu season, thus highlighting important considerations for biosafety. For decades, the Yamagata and Victoria lineages of the influenza B virus co-circulated globally, causing millions of infections in humans. Only Victoria reemerged after the COVID-19 pandemic. By combining mechanistic transmission modeling with worldwide influenza surveillance data, we show that Yamagata's extinction is most consistent with a lower intrinsic transmissibility than that of the surviving Victoria lineage. Contrary to other proposed explanations, differences in cross-immunity and immune escape appear insufficient to explain the observed outcome. Our analyses further indicate that Victoria narrowly avoided extinction during the COVID-19 disruption, but now transmission of Yamagata would be sustained if the lineage were reintroduced. These results inform both influenza eradication efforts and biosafety policy.

Transcranial magnetic stimulation (TMS) is widely used in both clinical and research settings to study and treat neurological and neuropsychiatric disorders, yet its underlying neural mechanisms remain unclear; particularly how stimulation influences both local and distant regional activity in relation to behavior. In this study, we combined single-pulse TMS with concurrent whole-head functional near-infrared spectroscopy (fNIRS) to examine hemodynamic and behavioral responses during a working memory task, with a focus on behavioral variability. Single TMS pulses were delivered to the left dorsolateral prefrontal cortex (DLPFC) while healthy participants rested; additionally, single pulses were delivered online to the left DLPFC while participants performed the working memory task. Across all participants, we observed a reliable load-dependent increase in hemodynamic activity associated with task. However, behavioral responses to TMS varied during the task. When participants were stratified into subgroups based on performance, a distinct topographic pattern emerged. During the task, TMS systematically modulated hemodynamic responses in regions including DLPFC, superior medial gyrus, precuneus, and parietal lobule, which are areas belonging to the default mode network. Moreover, the hemodynamic response during the single pulse alone sessions without any task was also found to be associated with the behavioral responses in a coherent pattern involving DLPFC, precuneus and parietal lobules. These findings suggest that variable behavioral outcomes during online TMS task are linked to distinct hemodynamic responses in a topographic pattern of local and distant regional areas.

Having achieved the UNAIDS 95-95-95 targets, Eswatini faces a growing burden of non-communicable diseases which are major contributors to morbidity and mortality. Hypertension-associated cardiovascular disease (CVD) is rising among people living with HIV (PLHIV) as survival improves and metabolic risks - including those linked to dolutegravir (DTG) - increase. We projected CVD burden among PLHIV and HIV-negative adults (PLWHIV) through 2045 to inform integrated HIV-CVD planning. EMOD-HIV, an agent-based model calibrated to Eswatini's epidemic, generated HIV prevalence trajectories. These were combined with age-standardized Global Burden of Disease CVD estimates and published relative risks (RRs) to produce HIV-stratified CVD projections. CVD burden trajectories were then projected through 2045 using a logistic generalized additive model with Monte Carlo uncertainty quantification. Five scenarios were evaluated to assess how different assumptions about RR of CVD among PLHIV versus PLWHIV affect projected burden: (1) CVD prevalence under a constant RR; (2) CVD mortality under a constant RR; (3) HTN-attributable CVD mortality under a constant RR; (4) HTN-attributable CVD mortality under a post-DTG RR increase following Eswatini's 2021 dolutegravir rollout; and (5) HTN-attributable CVD mortality under a gradual RR increase from 2010-2045 reflecting cumulative metabolic and demographic shifts. PLHIV consistently exhibited higher CVD burden than HIV-negative adults. Scenario 1: CVD prevalence was 11.0% (95% UI: 9.0-13.5%) among PLHIV versus 6.8% (6.0-7.8%) in 2025, stable through 2045. Scenario 2: CVD mortality rate was 0.60% (0.47-0.76%) versus 0.37% (0.31-0.45%) in 2025, declining modestly through 2045 with consistent excess. Scenario 3: HTN-attributable mortality was 73% (70-76%) versus 64% (61-66%) in women and 61% (58-64%) versus 58% (55-60%) in men, stable through 2045. Scenario 4: Following DTG rollout, mortality rose from 73% to 85% in women and 61% to 70% in men by 2022, remaining stable thereafter. Scenario 5: By 2045, mortality reached 85% (82-88%) in women and 67% (64-70%) in men with HIV, versus 60% (57 - 63%) and 55% (53 - 57%) in HIV-negative adults. While excess CVD burden among PLHIV is projected to persist even under stable risk conditions, ART-related metabolic trajectories - particularly those linked to DTG - may drive substantial widening of this gap through 2045. HTN-attributable CVD mortality is particularly elevated among women with HIV. Strengthening integrated HIV-NCD services, including blood pressure screening, risk-based therapy, and sex-specific DTG counseling, will be essential to sustain long-term health gains.